Australia markets closed

Integra LifeSciences Holdings Corporation (IART)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
61.85+0.49 (+0.80%)
As of 11:27AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
1,559,015
1,542,448
1,371,868
1,517,557
1,472,441
Cost of revenue
594,554
597,808
520,834
564,681
571,496
Gross profit
964,461
944,640
851,034
952,876
900,945
Operating expenses
Research development
94,762
93,051
77,381
79,573
78,041
Selling general and administrative
640,738
637,445
594,526
687,599
690,746
Total operating expenses
751,781
747,410
699,664
794,200
789,947
Operating income or loss
212,680
197,230
151,370
158,676
110,998
Interest expense
49,121
50,395
71,581
53,957
64,683
Total other income/expenses net
16,789
61,105
4,434
-55,394
8,288
Income before tax
186,714
214,677
93,520
60,104
57,403
Income tax expense
30,132
45,602
-40,372
9,903
-3,398
Income from continuing operations
156,582
169,075
133,892
50,201
60,801
Net income
156,582
169,075
133,892
50,201
60,801
Net income available to common shareholders
156,582
169,075
133,892
50,201
60,801
Basic EPS
-
2.00
1.59
0.58
0.72
Diluted EPS
-
1.98
1.57
0.58
0.72
Basic average shares
-
84,701
84,337
85,870
84,446
Diluted average shares
-
85,485
85,228
86,494
84,446
EBITDA
-
384,908
281,132
223,523
232,816